Source:http://linkedlifedata.com/resource/pubmed/id/19413884
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8B
|
pubmed:dateCreated |
2010-2-9
|
pubmed:abstractText |
Based on the capacity of mesenchymal stem cells (MSC) to differentiate into multiple cell types in vitro and in vivo, MCS may be a suitable source for cell therapy and regeneration strategies. A prerequisite for effective clinical applications of human MSC (hMSC) is a profound knowledge of signal transduction cascades that mediate processes like proliferation, targeted migration and differentiation. Recently, we identified the canonical Wnt signal transduction pathway as a key player in hMSC proliferation and invasion. To evaluate whether those findings are transferable to the equivalent counterparts in mice, we studied important steps in the wingless/int-1 (Wnt) signal transduction pathway in mouse MSC (mMSC) and mMSC carrying a T cell specific transcription factor (TCF)/lymphoid enhancer binding factor (LEF)-reporter transgene. We found that the induction of the canonical Wnt pathway resulted in the up-regulation of the known Wnt target gene cyclin D1, closely associated with an enhanced proliferation capacity of mMSC. Interestingly, the expression of the Wnt target gene membrane type 1-matrix metalloproteinase (MT1-MMP) was diminished in mMSC upon Wnt3a stimulation, which came along with an impaired invasion. In line with these findings, MMP-2 and MMP-9 expression levels in mMSC were also decreased after Wnt3a treatment. In contrast, inhibition of Wnt signalling by the knockdown of the transcriptional activator beta-catenin resulted in an up-regulation of MT1-MMP and mMSC invasion. By comparing these findings with the settings in hMSC, major differences in Wnt-regulated MMP expression were observed in mMSC. Thus, our data advice caution when mouse model systems represent the pre-clinical validation of MSC-mediated therapeutical approaches.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1582-4934
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2506-20
|
pubmed:meshHeading |
pubmed-meshheading:19413884-Animals,
pubmed-meshheading:19413884-Base Sequence,
pubmed-meshheading:19413884-Cell Proliferation,
pubmed-meshheading:19413884-DNA Primers,
pubmed-meshheading:19413884-Matrix Metalloproteinases,
pubmed-meshheading:19413884-Mesenchymal Stem Cells,
pubmed-meshheading:19413884-Mice,
pubmed-meshheading:19413884-Mice, Inbred C57BL,
pubmed-meshheading:19413884-Polymerase Chain Reaction,
pubmed-meshheading:19413884-RNA, Small Interfering,
pubmed-meshheading:19413884-Signal Transduction,
pubmed-meshheading:19413884-Wnt Proteins
|
pubmed:year |
2009
|
pubmed:articleTitle |
Wnt signalling in mouse mesenchymal stem cells: impact on proliferation, invasion and MMP expression.
|
pubmed:affiliation |
Division of Clinical Chemistry and Clinical Biochemistry, Department of Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany.
|
pubmed:publicationType |
Journal Article
|